• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Two-year clinical outcome after successful implantation of sirolimus-eluting and paclitaxel-eluting

Two-year clinical outcome after successful implantation of sirolimus-eluting and paclitaxel-eluting

来源 :第11届中国介入心脏病学大会 | 被引量 : 0次 | 上传用户：ltcool
【摘 要】
：
Background There are few studies comparing long-term outcomes of percutaneous coronary intervention (PCI) with different drug-eluting stents for long coronary lesions.The present study seeks to compar
【作 者】
：
YIN Dong DOU Ke-fei XU Bo YANG Yue-jin YOU Shi-jie 
【机 构】
：
Department of Cardiology,State Key Laboratory of Cardiovascular Disease,Fuwai Hospital,National Cent
【出 处】
：
第11届中国介入心脏病学大会
【发表日期】
：
2013年7期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background There are few studies comparing long-term outcomes of percutaneous coronary intervention (PCI) with different drug-eluting stents for long coronary lesions.The present study seeks to compare the 2-years clinical outcome after SES and PES implantation in a real-world setting of patients with long coronary lesions.
其他文献
Comparison of long-term clinical outcome after successful implantation of FIREBIRD sirolimus-and TAX
Background To compare the safety and efficacy at 24 months after successful implantation of FIREBIRDsirolimus-eluting stents and TAXUS paclitaxel-eluting stents in Chinese population Methods From Apri
会议
FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice:analysis of a large single c
Background Recent data has shown that sirolimus-eluting stents (SES) reduced not only the incidences of restenosis but also of target vessel revascularization (TVR).CYPHER and FIREBIRD stents are both
会议
TIMI myocardial perfusion frame count by angiography: a novel method to predict incomplete resolutio
Background TIMI Myocardial Perfusion Frame Count (TMPFC) developed by our medical center is a novel technique using coronary cine-angiography for quantifying the filling and clearance of contrast agen
会议
Study of high dose atorvastatin on preventing contrast-induced nephropathy in patients undergoing CA
Background To study the effects and mechanism of high dose atorvastatin on prevention of contrast-induced nephropathy.Methods All 180 patients undergoing CAG and/or PCI were randomly divided into 20 m
会议
Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-el
Background This study sought to evaluate the safety and efficacy of the NOYA stent which is a Cobalt Chromium-based sirolimus-eluting stent (SES) with DL-Polylactide biodegradable polymer (Medfavour M
会议
Can “hybrid stent implantation” improve the long-term safety without affecting efficacy adversely wh
Background Though DES almost solved problem ofrestenosis, safety issue caused by stent thrombsis is still the major concern of DES.We hypothesized that hybrid stem implantation (BMS for lesions locate
会议
Follow-up and analysis of clinical, angiographic features in patients with coronary artery chronic t
Background The aim of our study was to investigate the clinical and angiographic follow-up features and influential factors ofpercutaneous coronary intervention (PCI) outcome for chronic total occlusi
会议
Meat-analysis of genetic associations with coronary artery disease in the type 2 diabetic population
Background The mechanisms of both type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are multi-factorial but remain poorly understood.The "common soil" hypothesis suggests both disorder
会议
Recanalization strategy for chronic total occlusions with a new guidewire technique (“improved seesa
Background The success rate of percutaneous coronary intervention (PCI) for chronic total coronary occlusion (CTO)lesions varies depending on the guidewire manipulation skills of the operator.The stan
会议
Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary art
Background This study aimed to evaluate the association of serum levels of glycated albumin (GA) and endogenous secretory receptor for advanced glycation end products (esRAGE) with coronary artery rem
会议